Join
Live feed
·
PRReleasevia Quantisnow
Shineco, Inc. logo

Shineco, Inc. Intends to Acquire Biotechnology Company to Jointly Develop Rapid-acting Antidepressant Natural Innovative Medicine

ByQuantisnow·Wall Street's wire, on your screen.
TYHT· Shineco, Inc.
Consumer Non-Durables

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TYHT (Shineco, Inc.) and more on Quantisnow.